PCV89 PRASUGREL COST-EFFECTIVE RELATIVE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FROM THE PERSPECTIVE OF THE UK NATIONAL HEALTH SERVICE? A MODEL-BASED ANALYSIS
Abstract
Authors
A Davies M Sculpher C Schmitt A Barrett J Baird G Zanotti A Bakhai